The 25(OH)D level needed to maintain a favorable bisphosphonate response is ≥33 ng/ml

Vitamin D Insufficiency

(2011) Clifford J. Rosen   NEW ENGLAND JOURNAL OF MEDICINE

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

(2010) Patrick Garnero et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know

(2010) A. Catharine Ross et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Minimum Required Vitamin D Level for Optimal Increase in Bone Mineral Density with Alendronate Treatment in Osteoporotic Women

(2009) Muneaki Ishijima et al.   CALCIFIED TISSUE INTERNATIONAL

Screening for kidney disease in vascular patients: SCreening for Occult REnal Disease (SCORED) experience

(2009) H. Bang et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Effects of Two Years of Daily Teriparatide Treatment on BMD in Postmenopausal Women With Severe Osteoporosis With and Without Prior Antiresorptive Treatment

(2008) Barbara M Obermayer-Pietsch et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Osteoporosis treatment and fracture incidence: the ICARO longitudinal study

(2008) S. Adami et al.   OSTEOPOROSIS INTERNATIONAL

Vitamin D insufficiency does not affect response of bone mineral density to alendronate

(2008) D. M. Antoniucci et al.   OSTEOPOROSIS INTERNATIONAL

Vitamin D status and response to treatment in post-menopausal osteoporosis

(2008) S. Adami et al.   OSTEOPOROSIS INTERNATIONAL